INSULIN RESISTANCE AND GEOGRAPHICAL ORIGIN ARE MAJOR PREDICTORS OF LIVER FIBROSIS AND RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN IN GENOTYPE 4 CHRONIC HEPATITIS C PATIENTS

被引：2
作者：
Moucari, R. [1 ]
Ripault, M. -P. [1 ]
Martinot-Peignoux, M. [1 ]
Castelnau, C. [1 ]
Voitot, H. [1 ]
El Ray, A. [1 ]
Asselah, T. [1 ]
Boyer, N. [1 ]
Vidaud, M. [1 ]
Bedossa, P. [1 ]
Valla, D. [1 ]
Marcellin, P. [1 ]
机构：
[1] Hop Beaujon, Clichy, France
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)60637-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
635
引用
收藏
页码：S233 / S234
页数：2
相关论文
共 50 条
[31]   Microalbuminuria in hepatitis C-genotype 4: Effect of pegylated interferon and ribavirin [J].
Derbala, Moutaz ;
Shebl, Fatma M. ;
Rashid, Awad ;
Amer, Aliaa ;
Bener, Abdulbari .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (10) :1226-1231
[32]   Pegylated interferon plus ribavirin therapy is associated with improvement of the serum adiponectin and insulin resistance in patients with genotype 1b chronic hepatitis C [J].
Watanabe, Hisayoshi ;
Saito, Takafumi ;
Katsumi, Tomohiro ;
Tomita, Kyoko ;
Sato, Chikako ;
Ishii, Rika ;
Haga, Hiroaki ;
Okumoto, Kazuo ;
Nishise, Yuko ;
Suzuki, Yoshihiro ;
Suzuki, Katsunori ;
Ishibashi, Masamichi ;
Shinzawa, Haruhide ;
Ueno, Yoshiyuki ;
Kawata, Sumio .
HEPATOLOGY, 2012, 56 :1017A-1017A
[33]   Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4 [J].
Saad, Yasmin ;
Ahmed, Amal ;
Saleh, Doa'a A. ;
Doss, Wahid .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (08) :920-925
[34]   Pegylated Interferon Alfa-2a Plus Ribavirin in Chronic Hepatitis C Patients with Genotype 6 [J].
Pham, Thuy T. ;
Ho, Dat T. .
GASTROENTEROLOGY, 2009, 136 (05) :A840-A840
[35]   Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin [J].
Garib, Junia Rios ;
Garcia, Guilherme Freire ;
Teixeira, Rosangela ;
Lima e Silva, Francisco das Chagas .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (08) :625-631
[36]   INSULIN RESISTANCE DOES NOT PREDICT A RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A SUB-ANALYSIS OF THE MIST STUDY [J].
Prati, G. M. ;
Rumi, M. G. ;
Aghemo, A. ;
Soffredini, R. ;
D'Ambrosio, R. ;
De Nicola, S. ;
Degasperi, E. ;
Olgiati, L. ;
Donato, M. F. ;
Colombo, M. .
DIGESTIVE AND LIVER DISEASE, 2010, 42 :S44-S44
[37]   Using pegylated interferon and ribavirin to treat patients with chronic hepatitis C [J].
Ward, RP ;
Kugelmas, M .
AMERICAN FAMILY PHYSICIAN, 2005, 72 (04) :655-662
[38]   INSULIN RESISTANCE DOES NOT PREDICT A RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A SUB-ANALYSIS OF THE MIST STUDY [J].
Prati, G. M. ;
Rumi, M. G. ;
Aghemo, A. ;
D'Ambrosio, R. ;
De Nicola, S. ;
Olgiati, L. ;
Donato, M. F. ;
Colombo, M. .
JOURNAL OF HEPATOLOGY, 2010, 52 :S122-S122
[39]   Accurate models predicting response to pegylated interferon with ribavirin in patients with chronic hepatitis C as early as week 4 [J].
Martinot-Peignoux, M ;
Comanor, L ;
Minor, JM ;
Ripault, MP ;
Boyer, N ;
Castelnau, C ;
Giuily, N ;
Marcellin, P .
JOURNAL OF HEPATOLOGY, 2005, 42 :213-213
[40]   Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C [J].
S. K. Tohra ;
S. Taneja ;
S. Ghosh ;
B. K. Sharma ;
A. Duseja ;
R. K. Dhiman ;
A. Das ;
Y. K. Chawla .
Digestive Diseases and Sciences, 2011, 56
12345